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The Flagellum of Pseudomonas aeruginosa Is Required
for Resistance to Clearance by Surfactant Protein A
Shiping Zhang1, Francis X. McCormack1, Roger C. Levesque2, George A. O’Toole3, Gee W. Lau4*
1 Division of Pulmonary and Critical Care Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America, 2 Centre
de Recherche sur la Fonction Structure et Ingenierie des Proteines, Pavillon Charles-Eugene Marchand et Faculte de Medecine, Universite Laval, SteFoy, Quebec, Canada, 3 Department of Microbiology and Immunology, Dartmouth Medical School, Hanover, New Hampshire, United States of
America, 4 Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America

Surfactant protein A (SP-A) is an important lung innate immune protein that kills microbial pathogens by opsonization and
membrane permeabilization. We investigated the basis of SP-A-mediated pulmonary clearance of Pseudomonas aeruginosa
using genetically-engineered SP-A mice and a library of signature-tagged P. aeruginosa mutants. A mutant with an insertion
into flgE, the gene that encodes flagellar hook protein, was preferentially cleared by the SP-A+/+ mice, but survived in the SPA2/2 mice. Opsonization by SP-A did not play a role in flgE clearance. However, exposure to SP-A directly permeabilized and
killed the flgE mutant, but not the wild-type parental strain. P. aeruginosa strains with mutation in other flagellar genes, as
well as mucoid, nonmotile isolates from cystic fibrosis patients, were also permeabilized by SP-A. Provision of the wild-type fliC
gene restored the resistance to SP-A-mediated membrane permeabilization in the fliC-deficient bacteria. In addition, nonmucoid, motile revertants of CF isolates reacquired resistance to SP-A-mediated membrane permeability. Resistance to SP-A
was dependent on the presence of an intact flagellar structure, and independent of flagellar-dependent motility. We provide
evidence that flagellar-deficient mutants harbor inadequate amounts of LPS required to resist membrane permeabilization by
SP-A and cellular lysis by detergent targeting bacterial outer membranes. Thus, the flagellum of P. aeruginosa plays an indirect
but important role resisting SP-A-mediated clearance and membrane permeabilization.
Citation: Zhang S, McCormack FX, Levesque RC, O’Toole GA, Lau GW (2007) The Flagellum of Pseudomonas aeruginosa Is Required for Resistance to
Clearance by Surfactant Protein A. PLoS ONE 2(6): e564. doi:10.1371/journal.pone.0000564

general, rough bacterial mutants decorated with truncated LPS
species were more readily permeabilized by SP-A than smooth
strains [15–17], and incorporation of rough but not smooth LPS
multilamellar liposomes composed of bacterial phospholipids
conferred susceptibility to SP-A-mediated permeabilization [18].
We recently adapted signature tagged mutagenesis (STM) to
comparatively identify microbial factors that confer resistance or
susceptibility to SP-A [17]. Subsets of a P. aeruginosa library
composed of 6912 mutants containing individual gene insertions
were instilled into SP-A+/+ and SP-A2/2 mice. Mutants which are
cleared in an SP-A-dependent manner were tested for susceptibility to SP-A-mediated opsonization, phagocytic killing and
permeabilization. In this paper, we characterize a SP-A sensitive
P. aeruginosa mutant identified by comparative STM, the flagellar
mutant flgE.

INTRODUCTION
Pseudomonas aeruginosa is a ubiquitous Gram-negative pathogen and
a major cause of morbidity in patients with nosocomial pneumonia
and cystic fibrosis (CF). Environmental strains and most clinical
isolates of P. aeruginosa involved in acute infections are flagellated
and motile [1–3]. In contrast, approximately 39% of P. aeruginosa
isolated from chronically infected CF patients are nonmotile [4,5].
Other studies have suggested that exposure to airway surface
liquid from CF patients quickly represses the expression of P.
aeruginosa flagellin, the major structural protein of bacterial flagella
[6]. This repression is mediated by the AlgT-dependent transcriptional regulator AmrZ [7]. The P. aeruginosa flagellum is an
important virulence factor [3] and a potent activator of host
immunity [8]. A number of studies have shown that P. aeruginosa
strains lacking flagella are much less readily phagocytosed by
alveolar macrophages and polymorphonuclear leukocytes [4,5].
Thus, the loss of flagellar expression within the CF airway may
represent an adaptive response that allows P. aeruginosa to evade
detection and clearance by host defense mechanisms during the
chronic phase of CF lung infection [9].
SP-A is a large oligomeric protein composed of 18 subunits,
each containing a collagen-like sequence and a calcium-dependent
carbohydrate recognition domain, that is intimately associated
with surfactant phospholipids lining the air-liquid interface of the
lung [10,11]. Upon encountering an inhaled bacterial pathogen,
SP-A dissociates from the phospholipid membrane and binds to
the microbe by calcium dependent ligation of surface bacterial
glycoconjugates, including lipopolysaccharide. The association of
SP-A with the bacteria enhances uptake by phagocytes, and
modulates inflammatory responses including cytokine production
and the oxidant burst [11–14]. Recent data from our group
indicates that SP-A also directly inhibits the growth of gramnegative bacteria such as Escherichia coli, Bordetella pertussis, and P.
aeruginosa by permeabilizing the bacterial membrane [15–17]. In
PLoS ONE | www.plosone.org
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RESULTS
The P. aeruginosa Flagellar Gene flgE Confers
Resistance to SP-A
We utilized a P. aeruginosa PA01 STM mutant library [17,19] and
a SP-A deficient mouse model to identify putative microbial
targets for SP-A. We identified an STM mutant that was able to
grow in the lungs of SP-A2/2 but not SP-A+/+ mice, as indicated
by the presence of a PCR amplified oligo tag in bacterial output
from SP-A2/2 mouse lungs, and the absence of a PCR amplified
oligo tag in bacterial output from SP-A+/+ mouse lungs (Figure 1A).
The disrupted genetic locus was cloned by plasmid rescue and
sequenced. The DNA sequences flanking the transposon,
pUTminiTn5Km2 (Table 1), were analyzed by comparison with
online databases (www.pseudomonas.com), and revealed a transposon insertion into the flgE (PA1080) gene, (Figure 1B), between
nucleotide 1021 and 1022. Because the flgE gene is the final open
reading frame (ORF) within the operon that encodes four genes,
flgB, flgC, flgC and flgD, no polarity effect is expected. The flgE gene
encodes the hook structure on the flagellum from which the
flagellar filament protrudes (Figure 1C) [20]. The flgE mutant was
determined to harbor a single transposon insertion after
hybridization with the transposon vector pUTminiTn5Km2
(Table 1) (data not shown). A DNA fragment that flanked both
ends of the transposon integration in the flgE gene was cloned from
the wild-type PA01. A radiolabeled-probe that was synthesized
from the flanking DNA fragment hybridized to a higher molecular
weight Pst I restricted DNA fragment in the chromosome of the

Table 1. Bacterial Strains and Plasmids Used
......................................................................
Bacterial Strains Relevant characteristics

Reference

P. aeruginosa
PA01

Wild-type

46

PA01-gfp

PA01 harboring pUCP19-gfp

17

flgE

PA01 miniTn5Km2flgE, flagellar mutant

This study

PA01

Wild-type

M. Vasil [47]

PAO-fliC

PAO1 fliC::Gmr

27

PAOC-fliC

PAOC-complemented on the chromosome
with the PA01 fliC gene at the attB site

49

PAO-fliD

PAO1 fliD::Gmr

26

PA14

Wild-type

48

DmotAB

motAB deletion strain of PA14

29

DmotCD

motCD deletion strain of PA14

29

DmotAB DmotCD Both sets of mot genes, motAB and motCD
deleted from PA14

29

flgK

PA14 flgK::Tn5(Tcr)

32

CF 51

mucoid CF isolate

This study

CF51N

nonmucoid revertant of CF51

This study

CF90

mucoid CF isolate

This study

CF90N

nonmucoid revertant of CF90

This study

Plasmids
pUTminiTn5Km2

R6K-based suicide delivery plasmid, Kmr

19

pUCP19-gfp

polylinker lacZ, laciq selection, bla, gfp

17

PVL1393

bla

Invitrogen
(Carlsbad, CA)

doi:10.1371/journal.pone.0000564.t001

flgE mutant than the parent strain PA01 (Figure 1D). These results
confirmed that the transposon inserted singly into the flgE gene.

The SP-A-sensitive STM Mutant, flgE, Competes
Poorly With the Parental PA01 Strain in the Lungs of
SP-A+/+ Mice
Apart from confronting pulmonary host defenses, the STM
screening strategy used requires individual mutants to compete with
71 other STM mutants within individual library pools. Competitive
mixed infection assays have been used to assess the fitness of
individual mutants versus their parental strains during in vivo
infection [17,21]. When inoculated with equal numbers of withtype PA01 into the lungs of mice, the flgE mutant was only 33% as
competitive as PA01 in SP-A+/+ animals (Figure 2A). In contrast, the
flgE mutant competed comparably, if not better than, the wild-type
PA01 in SP-A2/2 mice (Figure 2A). We also tested the flgE mutant
in single infection studies. Eighteen hours after intranasal inoculation, the viable bacterial counts of flgE mutant bacteria were 1.3
log higher in lung homogenates from SP-A2/2 mice compared to
SP-A+/+ mice (Figure 2B). Our results indicate that flagellar function
plays an important role against SP-A-mediated clearance of P.
aeruginosa.

Figure 1. The Flagellar Mutant flgE Is Preferentially Cleared from the
Lungs of SP-A+/+ Mice. (A) Pools of 72 uniquely-tagged mutants were
intranasally inoculated into three SP-A+/+ (M1, M2, M3) and three SP-A2/
2
(m1, m2, m3) mice. Mouse lungs were harvested, homogenized and
plated. Bacteria colonies were collected for genomic DNA extraction.
PCR-amplification of tags was performed to screen for the presence or
absence of each of the 72 mutants. The band indicative of the flgE
mutant was present in the SP-A2/2 pool, but absent in the SP-A+/+ pool.
(B) Genetic organization of the flg operon in P. aeruginosa. The
horizontal arrows (flgB, flgC, flgD, flgE, flgF) represent transcriptional
directions of the genes coding for flagella proteins. The vertical black
arrow indicates the approximate insertion site within the mutated open
reading frame of flgE. (C) A schematic representation of flagellar
structure. FliC is flagellar filament protein, FliD is flagellar cap protein,
FlgE is flagellar hook protein, and FlgK is flagellar hook associated
protein. (D) Restriction fragment length polymorphism analysis
between wild-type PA01 and flgE mutant indicates that the flgE
mutation was caused by transposon insertion into the cloned gene.
doi:10.1371/journal.pone.0000564.g001

PLoS ONE | www.plosone.org

Opsonization by SP-A Does Not Play A Role in the
Preferential Clearance of the flgE Mutant In Vivo
Previous studies have demonstrated that flagella act as a major
ligand for nonopsonic phagocytosis of P. aeruginosa, and are
required to trigger internalization [4–5]. Consequently, P.
2
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Figure 2. The flgE Mutant Is Attenuated in SP-A+/+ Mice. (A) In vivo
competition between the PA01 and flgE was assessed after intranasal
pulmonary inoculation of 6-week old SP-A+/+ and SP-A2/2 mice. The
mean competitive index (CI) was calculated from bacterial colonies
recovered 16 hr after infection. The competitive index (CI) is defined as
the output ratio of mutant to wild-type bacteria divided by the input
ratio of mutant to wild-type bacteria. Data are the mean6SE, n = 4.
*p,0.05. (B) Single respiratory tract infection of flgE mutant bacteria
was performed by intranasal inoculation in SP-A+/+ and SP-A2/2 mice.
CFU were counted in lung homogenates 16 hr after inoculation. Data
are the mean CFU6SE, n = 5. *p,0.01.
doi:10.1371/journal.pone.0000564.g002

aeruginosa lacking flagella are resistant to nonopsonic phagocytosis
by macrophages and neutrophils. In multiple studies, SP-A has
been reported to opsonize pathogens and enhance their phagocytosis by alveolar macrophages and neutrophils [22–24]. To rule
out SP-A-mediated opsonization contributed to the differential
clearance of flgE mutant in SP-A mouse models, we compared the
phagocytosis of flgE to PA01 bacteria in SP-A+/+ and SP-A2/2
mice after intranasal inoculation in vivo, and in the presence and
absence of SP-A, in vitro. Macrophages with internalized GFPexpressing flgE and PA01 were enumerated by phase contrast
fluorescence microscopy. Uptake of PA01 bacteria was noted in
42.167.6% of alveolar macrophages isolated 2 hr after intranasal
inoculation from SP-A+/+ mice, compared to 28.563.0% of alveolar
macrophages with PA01 from SP-A2/2 mice (Figure 3A). These
results suggest that SP-A facilitates the in vivo macrophage-mediated
phagocytosis of PA01 bacteria, which have intact flagella. In
contrast, the loss of flagella in flgE mutant bacteria results in lower
total uptake by alveolar macrophages when compared to wild-type
PA01 bacteria. Specifically, flgE bacteria were internalized in only
19.865.7% of alveolar macrophages from SP-A+/+ mice compared
with 12.765.1% from SP-A2/2 mice (Figure 3A). Thus, in vitro, SPA enhanced phagocytosis of PA01 by approximately 50% but did
not have any effect on the phagocytosis of flgE bacteria (Figure 3B).
Similarly, as shown in Figure 3C, the uptake of PA01 and the flgE
mutant by neutrophils were not increased in the presence of SP-A
PLoS ONE | www.plosone.org

Figure 3. SP-A-Mediated Opsonization Does Not Play A Critical Role
in the Preferential Clearance of flgE Bacteria. (A) Analysis of in vivo
phagocytosis was performed by intranasally inoculating live, GFPexpressing PA01 and flgE bacteria into SP-A+/+ and SP-A2/2 mice (n = 3).
Macrophages were recovered by bronchoalveolar lavage 2 hr later. The
percentage of macrophages with internalized bacteria was determined
using a phase contrast fluorescence microscope. Two hundred
macrophages were counted for each mouse. Data are the mean6SE,
n = 3. *p,0.05. (B) Analysis of in vitro phagocytosis was performed using
live, GFP-expressing PA01 and flgE bacteria with alveolar macrophages
isolated from SP-A2/2 mice. The percentage of macrophages with
internalized bacteria was determined using a phase contrast fluorescence microscope. Two hundred macrophages were counted for each
mouse. Data are the mean6SE, n = 3. *p,0.01. (C) In vitro phagocytosis
of PA01 and flgE by human neutrophils isolated from the blood of
healthy volunteers. Phagocytosis experiments were performed as
described for (A). Two hundred neutrophils were counted. Data are
the mean6SE, n = 3. *p,0.05. PMN = Neutrophils. M = Macrophages.
doi:10.1371/journal.pone.0000564.g003

(Fig. 3C). In fact, SP-A-opsonized PA01 was phagocytosed less
efficiently than untreated bacteria by neutrophils. However, the
uptake of PA01 was significantly greater than flgE, irrespective of the
presence or absence of SP-A.
Collectively, our results suggest that while flagella enhance
internalization of P. aeruginosa into macrophages and neutrophils,
3
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SP-A-mediated macrophage and neutrophil phagocytosis are not
responsible for the preferential clearance of flgE mutant bacteria
from SP-A+/+ mice. These results also confirm data from other
studies that flagella serve as critical ligands for the internalization
of bacteria [4,5].

that was 3.3 and 4.4 fold greater than the wild-type strain PA01,
respectively, at 120 min post-exposure to SP-A (Figures 4, B and
C). The levels of PAO-fliC and PAO-fliD bacteria susceptibility
were comparable to the flgE mutant (Figure 4A), and to the E. coli
K12 [15]. These results indicate that an intact flagellum or
flagellar function is essential for resistance to SP-A-mediated
membrane permeabilization, and is consistent with previous
finding that flagellum is required for acute lung infection by P.
aeruginosa [3].
To confirm that the loss of flagella confers susceptibility of P.
aeruginosa to SP-A, we determined if provision of the wild-type fliC
gene in trans to the fliC-deficient mutant bacteria could restore the
resistance to SP-A-mediated membrane permeabilization. Importantly, while PAO-fliC mutant bacteria were susceptible to SP-Amediated membrane permeabilization, the complemented PAOCfliC bacteria, were as resistant to SP-A-mediated membrane
permeabilization as the wild-type PA01 (Figure 4D). These results
indicate that an intact flagellar structure or function is important
in protecting P. aeruginosa from membrane destabilization by SP-A.

An Intact Flagellum is Required to Confer Resistance
of P. aeruginosa to SP-A-mediated Membrane
Permeabilization
We have recently shown that SP-A is capable of directly killing
Gram-negative bacteria and fungi by membrane permeabilization
and inhibition of macro-molecular synthesis, independent of
macrophage-mediated phagocytosis [15,17,25]. We examined
whether direct membrane permeabilization contributed to the
preferential clearance of the flagellar-deficient flgE mutant. The
flgE mutant bacteria were permeabilized by SP-A to an extent that
was 3.4 fold greater than the wild-type strain PA01 after exposure
to SP-A for 120 minutes (Figure 4A).
We postulate that the susceptibility of the flgE mutant to SP-Amediated membrane permeabilization is due to its inability to
assemble a flagellum. We tested additional flagellar mutants, fliC
(PAO-fliC) and fliD (PAO-fliD) [26,27], for their susceptibility to
membrane permeabilization by SP-A. The fliC gene encodes
flagellin, which comprises the filament of a flagellum whereas the
fliD gene encodes the cap of a flagellum (Figure 1C). Both PAOfliC and PAO-fliD mutant bacteria exhibited increased susceptibility to SP-A-mediated membrane permeabilization to an extent

Membrane Permeabilization by SP-A Directly Kills
Flagellar Mutants
We next determined if SP-A-mediated membrane permeabilization kills flagellar mutants. Live/dead staining, based on exclusion
of propidium iodide from the live cells, was immediately
performed on bacterial cells following 120 min of exposure to
SP-A. Viable cells are stained green while dead cells are stained

Figure 4. SP-A Preferentially Permeabilizes Flagellum-Deficient Mutants of P. aeruginosa. (A–C) SP-A preferentially permeabilizes flagellumdeficient flgE, fliC and fliD mutants. Bacterial cells from the wild-type PA01 and mutant strains flgE, fliC (PAO-fliC), and fliD (PAO-fliD) were exposed to
50 mg/ml human SP-A in the presence of the phosphatase substrate ELF97. Fluorescence was measured for 120 min using a fluorimeter and
expressed as arbitrary units (a.u.). Data are the mean6SE, n = 6–8. The difference in membrane permeabilization between flgE mutant and PA01 was
significant from 31st-min onward. *p,0.05. The differences in membrane permeabilization between PAO-fliC and PA01, and between PAO-fliD and
PA01 were both significant from 32nd-min onward, respectively. *p,0.05. (D) Genetic complementation of flagellar function restores resistance to SPA-mediated membrane permeabilization. PAOC-fliC (open square), a fliC mutant harboring a copy of wild-type fliC gene is as resistant to SP-Amediated membrane permeabilization as the parental strain PA01 (open circle). Data are the mean6SE, n = 6. The differences in membrane
permeabilization between fliC and PA01, and between fliC and PAOC-fliC, were significant from 32nd-min, and 34th-min onward, respectively.
*p,0.05.
doi:10.1371/journal.pone.0000564.g004
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Figure 5. SP-A Directly Kills flgE by Membrane Permeabilization. (A)
Live/dead staining was performed on E. coli K12, PA01 and flgE cells
following incubation with 50 mg/ml SP-A. Green-stained cells are alive
whereas red-stained cells are dead. Robust aggregation of E. coli K12
but not P. aeruginosa strains by SP-A was observed. (B) Enumeration of
live or dead bacteria following a 1 h exposure to hSP-A. At least 1,000
bacterial cells were counted under a fluorescence microscope. The
mean6SD of two experiments is shown.
doi:10.1371/journal.pone.0000564.g005

red. As shown in Figure 5A, SP-A did not kill wild-type PA01
(green stained). In contrast, mixtures of green- and red-stained
cells of flgE were visible following treatment with SP-A.
Approximately 11% of the flgE bacteria were killed within
60 minutes of exposure to SP-A. Bacterial aggregation can affect
viability. However, in contrast to the robust SP-A induced
aggregation of E. coli K12, SP-A did not aggregate PA01 or flgE
bacteria (Figure 5B). These results suggest that the loss of flagella
render the P. aeruginosa vulnerable to membrane permeabilization
and killing by SP-A. Furthermore, aggregation of P. aeruginosa is
unlikely to play a role in the preferential clearance of the flagellar
mutants.

Figure 6. Nonmucoid Motile Revertants of Clinical CF P. aeruginosa
Strains Are More Resistant to SP-A-Mediated Membrane Permeabilization Than Their Parental Isolates. (A–B) The mucoid clinical CF P.
aeruginosa strains CF51 and CF90 were nonmotile, whereas their
nonmucoid motile revertants CF51N and CF90N had regained their
flagellar-based motility on swimming motility agar plates. The wild-type
strain PA01was used as control for motility assay. (C–D) Both CF51N and
CF90N were more resistant to SP-A-mediated membrane permeabilization than their parental isolates, CF51 and CF90, respectively. Data are
the mean6SE, n = 8 for each bacterial strain. The differences in
membrane permeabilization between CF51 versus PA01; CF51 versus
CF51N; and CF51N versus PA01 were significant from 43rd-min, 53rd-min
and 53rd-min onward, respectively. *p,0.05. The difference in
membrane permeabilization between CF90 versus PA01; CF90 versus
CF90N; and CF90N versus PA01 was significant from 38th-min, 28th-min,
and 43rd-min onward, respectively. *p,0.05.
doi:10.1371/journal.pone.0000564.g006

Mucoid, Nonmotile P. aeruginosa Isolated from CF
Patients are Susceptible to SP-A-mediated
Membrane Permeabilization
As discussed earlier, significant numbers (39%) of P. aeruginosa
strains isolated from chronically-infected CF patients are both
mucoid and nonmotile [4]. The loss of motility is due, in part, to
repression of flagellar biosynthesis by the AlgT-dependent
transcriptional regulator AmrZ [7] induced by the CF airway
fluids [6]. However, mucoid, nonmotile CF P. aeruginosa isolates
frequently revert to nonmucoid, motile phenotypes when they are
grown in static culture under laboratory conditions [28]. We
examined the effect of SP-A on two mucoid, nonflagellated strains
of P. aeruginosa isolated from CF patients. Strains CF51 and CF90
were nonmotile (Figure 6, A and B), and membrane permeabilized
by SP-A to an extent that was 3.2 fold and 3.6 fold greater than the
wild-type strain PA01, respectively, after 120 min exposure
(Figure 6, C and D). The levels of membrane permeabilization
in these two CF strains were similar to flagellum-deficient flgE, fliC
and fliD mutants. The overall correlation of flagellar motility and
resistance to membrane permeability are summarized in Table 2.
PLoS ONE | www.plosone.org

Nonmucoid, Motile Revertants of CF P. aeruginosa
Isolates Reacquire Resistance to SP-A-mediated
Membrane Permeabilization
If P. aeruginosa flagella play critical roles in resistance to SP-Amediated membrane permeability, we predicted that nonmucoid,
motile revertants of CF isolates CF51 and CF90, named CF51N
and CF90N, would have increased resistance to SP-A-mediated
membrane permeabilization. Both revertants were nonmucoid,
and determined to be motile by swimming motility assay (Figure 6,
A and B). The levels of resistance to SP-A-mediated membrane
permeabilization were increased by 2.0 and 1.7 fold in CF51N and
CF90N, respectively, when compared to parental strains CF51
and CF90 (Figure 6, C and D; Table 2). Collectively, these results
confirm that P. aeruginosa flagellum plays a crucial role in conferring
resistance to SP-A-mediated membrane permeabilization.
5
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Table 2. Correlation of Flagellum Production, Motility and SPA-Mediated Membrane Permeabilization
......................................................................
Bacterial strains

Flagellum

Motility

Membrane
permeabilization*

PA01 (Wild-type)

+

+++

-

flgE

-

-

4.3

fliC

-

-

4.1

fliD

-

-

4.5

PAOC-fliC

+

+++

-

PA14 (Wild-type)

+

+++

-

flgK

-

-

7.9

DmotAB

+

+

-

DmotCD

+

++

-

DmotAB DmotCD

+

-

-

CF51

-

-

3.2

CF51N

+

++

1.6

CF90

-

-

3.8

CF90N

+

+

2.4

Figure 7. Susceptibility to SP-A-Mediated Membrane Permeabilization Is Dependent on Intact Flagellum Structure but Independent of
Flagellar-Mediated Swimming Motility. (A) Wild-type P. aeruginosa
strain PA14 and its isogenic derivative dmotAB, dmotCD and dmotAB,
dmotCD were tested for swimming motility and susceptibility to SP-Amediate membrane permeabilization. Mutant strains dmotAB and
dmotCD were motile, but dmotAB, dmotCD was nonmotile on swimming
motility agar plate. (B) All dmotAB, dmotCD and dmotAB, dmotCD
mutant strains were resistant to SP-A-mediated membrane permeabilization, indicating that susceptibility to SP-A is independent of flagellarmediated motility. (C) The flgK mutant, which could not assemble
flagellum, was nonmotile. (D) The flgK mutant was susceptible to SP-Amediated membrane permeabilization. Data were the mean6SE, n = 8
for each bacterial strain. The difference in membrane permeabilization
between flgK and PA14 was significant from 31st-min onward. *p,0.05.
doi:10.1371/journal.pone.0000564.g007

*

Flagellum production was determined by motility assay. Extent of motility was
assessed by examining the radius of opacity as a result of bacterial swimming
away from the inoculation point. Permeability was determined by measuring
the ELF97 fluorescence at excitation and emission wavelengths of 355 and
535 nm.
doi:10.1371/journal.pone.0000564.t002

Susceptibility to SP-A-mediated Membrane
Permeabilization is Dependent On An Intact
Flagellum Structure but Independent of
Flagellar-mediated Swimming Motility
The susceptibility of flagellum-deficient mutants to SP-A could be
due to changes in membrane fluidity and rigidity, or due to the
loss of motility function. We examined whether the nonmotile P.
aeruginosa mutants that harbor intact flagella were resistant to
membrane permeabilization by SP-A. We utilized P. aeruginosa
mutants with deletions in motAB, motCD or motAB motCD genes, all
of which encode the stator for flagellum [29]. The stator
conducts protons across the inner membrane and couples proton
transport to rotation of the flagellar motor [30]. The phenotypic
analysis of the deletion mutants demonstrated that the MotAB
and MotCD proteins are functionally redundant for swimming
(Fig. 7A), as well as for swarming in relatively low agar
concentrations [29]. However, under higher agar concentrations,
the motCD mutant is unable to swarm [29]. The double mutant
dmotAB dmotCD can neither swim (Figure 7A) nor swarm under
any conditions tested, but still makes a flagellum [29].
Importantly, dmotAB, dmotCD and dmotAB, dmotCD were all as
resistant to SP-A-mediated membrane permeabilization as their
parental wild-type PA14 (Figure 7B). As a control, we
demonstrated that flgK mutant, which was derived from PA14,
and unable to assemble a flagellum due to the lack of the flagellar
hook-associated protein, was nonmotile (Figure 7C) and membrane permeabilized by SP-A to an extent that was 7.9-fold
greater than its wild-type parental strain, PA14. These results
indicate that resistance to SP-A-mediated membrane permeabilization is dependent on the presence of an intact flagellar
structure, rather than the motility function mediated by
flagellum.
PLoS ONE | www.plosone.org

The Loss of Flagellum Reduces the Ability of
P. aeruginosa to Express Adequate LPS and
Destabilize Its Outer Membranes
We have previously shown that LPS is essential for resistance to
SP-A-mediated membrane permeabilization in P. aeruginosa [17].
We determined whether the loss of flagellum negatively affected
LPS levels on the outer membrane of P. aeruginosa, which could
lead to susceptibility to SP-A. As shown in Figure 8A, the amounts
of the LPS inner core sugars on P. aeruginosa was dramatically
reduced after 15 min exposure to SP-A. However, the reduction is
much more severe in the flgE mutant (230%) when compared to
wild-type PA01 (213.5%). At 30 min post-SP-A exposure, PA01
increased the synthesis of inner core sugars by +23.6% in
comparison to +14.1% for flgE. Furthermore, using an antibody
against the B-band O-antigen, the flgE mutant was found to
harbor 48% and 50% less LPS than the wild-type PA01 during
both logarithmic and stationary phases of growth, respectively, in
the absence of SP-A (Figure 8B). Collectively, these results suggest
that the flagellar-deficient flgE mutant bacteria express lower levels
of LPS on its outer membrane.
Gram-negative bacteria with defects in their outer membranes are
well known to be more sensitive to lysis by detergents, including
sodium dodecyl sulfate (SDS). We examined the flagellar-deficient
mutants flgE, fliC and fliD for their increased susceptibility to 0.25%
SDS. As shown in Figure 8C, all three mutants were more sensitive
to lysis by SDS. In contrast, the wild-type PA01, and PAOC-fliC
(complemented fliC mutant) were equally more resistant to SDS.
6
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Figure 8. Mutation in the flgE Gene Reduces the Ability of P. aeruginosa to Synthesize LPS Both in the Presence and in the Absence of SP-A. (A–
B) The flgE mutant has reduced ability to synthesize the inner core (A) and B-band-O-antigen (B) of LPS. The induction of LPS biosynthesis was
measured using a monocloncal antibody against the inner core sugars and B-band O-antigen of LPS. The fold of increase was quantified against
controls using a densitometer. (C) Flagellar mutants are more susceptible to cell lysis by SDS. Wild-type PA01 and the complemented PAOC-fliC
strains are more resistant to 0.25% SDS than the flagellum-deficient mutants flgE, fliC and fliD. Experiments were repeated five times with similar
results. The results from one typical experiment are shown.
doi:10.1371/journal.pone.0000564.g008

a flagellum but is nonmotile [29], is as resistant to SP-A-mediated
membrane permeabilization as its isogenic wild-type parental
strain, PA14. Thus, it is likely that susceptibility of flagellardeficient mutants to SP-A-mediated membrane permeabilization
is caused by alterations to the outer cell membrane, such as LPS
density, charge distribution or phosphohlipid packing density.
Several lines of evidence support our prediction: Firstly, we found
that exposure to SP-A induced higher levels of LPS in the wildtype P. aeruginosa PA01 than its isogenic flgE mutant bacteria.
Secondly, flgE bacteria contain reduced levels of LPS during both
logarithmic and stationary phases of growth. Thirdly, flagellardeficient mutants flgE, fliC and fliD were all more susceptible to
0.25% SDS, indicative of weakened outer membranes.
Because the nonmotile dmotAB, dmotCD mutant is resistant to
SP-A, the susceptibility to SP-A appears to be independent of
flagellar-mediated motility functions. However, we are unable to
rule out other flagellum-dependent mechanisms that may protect
P. aeruginosa from SP-A-mediated membrane permeabilization,
including swimming chemotaxis and swarming motility [31], and
initiation of biofilm formation through attachment to substrates
[32]. Swarming motility is a flagellum-dependent, coordinated,
multicellular behavior promoting rapid bacterial colony migration
and expansion on more viscous surface, such as the epithelial
lining layer that P. aeruginosa encounters after inhalation into the
alveolar space. In numerous species of Gram-negative bacteria
including P. aeruginosa, swarmer cells alter their cellular morphology as well as induce the expression of PmrA-B regulated LPS
modification genes pmrHFIJKLMN, and other LPS biosynthesis
genes that are required for successful swarming [33], probably by
increasing wettability. Overexpression and modification of LPS
contributes to higher levels of resistance to antimicrobial peptides
and antibiotics in swarming Gram-nagative bacteria [31,33]. As
such, swarming P. aeruginosa cells may be more resistant to SP-Amediated membrane permeabilization. It is also conceivable that

These results support the notion that that the loss of flagellum
reduces the expression of LPS and the stability of outer membranes
on P. aeruginosa, rendering them susceptible to SP-A-mediated
membrane permeabilization and lysis SDS.

DISCUSSION
In this study, we screened a library of P. aeruginosa mutant bacteria
in SP-A null and sufficient mice for mutations with increased
susceptibility to pulmonary clearance by SP-A. One SP-A sensitive
P. aeruginosa mutant with a disruption in flgE, a gene required for
flagellar function, was identified. Enhanced uptake by phagocytes
did not play a role in the preferential clearance of flgE bacteria,
consistent with previous findings that flagellum-deficient mutants are
resistant to phagocytosis by macrophages and neutrophils [4,5].
Rather, flgE bacteria were more readily membrane permeabilized
and killed by SP-A than its wild-type parental strain, PA01. The
importance of flagella in resisting the membrane destabilizing
activities of SP-A was verified by multiple independent methods:
Firstly, we showed that additional flagellar mutants fliC, fliD and flgK
were also susceptible to SP-A-mediated membrane permeabilization. Secondly, genetic complementation of the fliC mutation with
a copy of wild-type fliC gene restored resistance to SP-A-mediated
membrane permeabilization. Thirdly, mucoid, nonmotile CF
isolates of P. aeruginosa were also membrane permeabilized by SPA. Finally, motile, nonmucoid revertants derived from the SP-Asusceptible CF isolates were able to reacquire resistance to SP-A.
These results reveal that flagellum plays critical roles in conferring
resistance to membrane permeabilization by SP-A.
Our genetic analysis suggests that the presence of the flagellar
structure rather than the flagellar-dependent motility is largely
responsible for the resistance to SP-A-mediated membrane
permeabilization. This conclusion is derived from our experimental evidence showing that the dmotAB, dmotCD mutant, which has
PLoS ONE | www.plosone.org

7

June 2007 | Issue 6 | e564

Flagella Resist SP-A Killing

the loss of swimming chemotaxis in the flagellum-deficient mutants
render them unable to escape alveolar microenvironments in
which SP-A is enriched, such as in surfactant-containing
compartments. Another possible explanation, though less likely,
is the inability of flagellar mutant to form biofilms. Flagellummediate attachment to substrate is the first step in the initiation of
biofilm formation [32], a mode of growth which is known to
contribute to the resistance of bacteria to antibiotics and other
antimicrobial agents [34,35]. However, biofilms mode of growth is
thought to be more important in chronic model of infection, as in
the airways of CF patients [9,36], rather than in the acute
pneumonia model of infection.
We found that motile, nonmucoid revertants derived from CF
P. aeruginosa strains, CF51N and CF90N, were more resistant to
SP-A-mediated membrane permeabilization than their mucoid,
nonmotile parental isolates CF51 and CF90. This transition
correlated with the reacquisition of swimming motility. However,
the resistance of CF51N and CF90N to SP-A-mediated membrane
permeabilization was not as prominent when compared to the
laboratory wild-type strain PA01. There are several possible
explanations for this discrepancy. Firstly, it is likely that PA01 and
CF51 and CF90 have different levels of intrinsic resistance to SP-A
as these are not isogenic strains. Secondly, it is well known that
many CF isolates of P. aeruginosa harbor mutated forms of LPS. In
particular, CF isolates often undergo mutations in genes that
participate in the biosynthesis of the highly antigenic B-band Oantigen of LPS [37], which is important for P. aeruginosa’s
resistance to SP-A [17]. Thus, LPS mutations in the CF51N and
CF90N revertants may explain the incomplete restoration of
resistance to SP-A-mediated membrane permeabilization even
though the flagellar expression is reacquired.
Reduction in the SP-A levels of the alveolar lining fluid, as has
been reported in bacterial pneumonia, adult respiratory distress
syndrome and CF [38–40], may play a role in the susceptibility to
pulmonary microbial colonization and infection. Proteases released
by neutrophil [41] and P. aeruginosa [42,43] are the most likely causes
of SP-A depletion. Thus, the much-reduced SP-A levels within
diseased CF airways may create an environment for P. aeruginosa to
safely repress the synthesis and assembly of the energy consuming
and highly proinflammatory flagella [8]. In addition, the loss of
flagellum will also decrease the chance of P. aeruginosa being
phagocytized by SP-A-facilitated macrophage and neutrophils.
Our results suggest that the killing of flagellum-deficient mutants
is more robust in vivo than in vitro. One likely explanation for the
discrepancy is that our in vitro membrane permeability conditions
do not accurately model the environment in the lung. It is also
possible that other antimicrobial factors within alveolar space,
including SP-A, SP-D, lactoferrin, b-defensins and other antimicrobial peptides and proteins [44,45], collectively contribute to the
killing of P. aeruginosa in vivo. We are currently examining whether
these peptides act synergistically in clearance of P. aeruginosa.
In summary, our data suggest that P. aeruginosa flagella play an
important role in resistance to pulmonary clearance by SP-A and
in particular to SP-A-mediated membrane permeabilization.
Therapeutic strategies aimed at blocking flagellar biosynthesis or
formation, or aerosolizing SP-A or SP-A fragments into septic
airways where SP-A levels are severely depleted, may be
reasonable therapeutic approaches to explore in the future.

Bacterial strains, plasmids, media and growth
conditions
All bacterial strains, plasmid vectors, and their derivatives are
described in Table 1. Two P. aeruginosa PA01 strains [46,47] and
PA14 [48] were the wild-type strains used in the present study.
The P. aeruginosa STM library [19] was created by random
insertion of the transposon pUTmini-Tn5 into the genome of
PA01 strain from Holloway et al [46]. The PAO-fliC [27] and
PAO-fliD [26] mutants, and the complemented fliC strain PAOCfliC [49], and their isogenic parental PA01 (originally from Mike
Vasil, see Table 1) [47] were the same as previously described. The
flgK, dmotAB, dmotCD and dmotAB, dmotCD mutants, which were
derived from PA14, was as previously described [29,32]. Two
mucoid clinical isolates of P. aeruginosa, CF51 and CF90, were
obtained from the University of Cincinnati Adult Cystic Fibrosis
Center following approval by the Institutional Review Board at
the University of Cincinnati. Escherichia coli K12 used as a control in
some experiments was transfected with the plasmid PVL 1393
(Invitrogen, Carlsbad, CA) to confer ampicillin resistance. Plasmid
pUCP19GFP (GFP+ Apr), which constitutively expresses gfp, was
used to label the strains for microscopic studies. Bacterial strains
were grown in Luria broth (LB) for 16 hr at 37uC, and then
suspended in LB with 20% glycerol and frozen in aliquots at
280uC. Before each assay, aliquots of the bacteria were cultured
from frozen stocks in liquid LB or on LB agar plates (1.5% agar)
with or without antibiotics for 3–16 hr at 37uC with continuous
shaking, and then suspended in Tris-buffered saline, pH 7.4.
Bacteria were cultured to stationary growth phase (OD600<3.0)
as indicated. The optical density at 600 nm was determined by
spectrophotometry and correlated with numbers of viable bacteria
by colony-forming units (cfu) after plating serial dilutions on agar
plates. The antibiotic concentrations used were as follows: for E.
coli, ampicillin (100 mg/ml); for P. aeruginosa, carbenicillin (300 mg/
ml), gentamycin (100 mg/ml), kanamycin (100 mg/ml), rifampicin
(50 mg/ml) and tetracycline (100 mg/ml).

Purification of human SP-A
Human SP-A was purified from the lung washings of patients with
alveolar proteinosis by a modification of the method of Suwabe et
al, [50] and stored in 5 mM Tris, 150 mM NaC, pH 7.4, at
220uC. The preparations were deemed free of EDTA by
a modified spectrophotometric assay of Kratochvil and White,
using ß-phenanthrolene–disulfonic acid as the indicator [51].

Protein assays
Routine protein concentrations were determined with a bicinchoninic acid protein assay kit (BCA; Pierce Chemical Co., Rockford,
Illinois, USA) using BSA as a standard. Protein samples were
separated on 8–16% SDS-PAGE gel and stained with Coomassie
blue or silver.

Animal husbandry
Swiss Black SP-A2/2 mice (a gift of J. Whitsett/T. Korfhagen)
were developed from embryonic stem cells after disruption of the
mouse SP-A gene by homologous recombination and maintained
by breeding with Swiss Black mice, as previously reported [52].
The SP-A null allele was bred into the C3H/HeN background
through nine generations, as described [15]. C3H/HeN control
(SP-A+/+) mice were purchased from Charles River Laboratory
(Boston). All comparisons made with the SP-A2/2 mice were with
age and strain-matched C3H/HEN controls. All animals were
housed in positively ventilated microisolator cages with automatic

MATERIALS AND METHODS
Reagents
All chemicals, except where noted, were obtained from Sigma
Chemical Co. (St. Louis, MO).
PLoS ONE | www.plosone.org
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described [53]. Neutrophil phagocytosis was performed as
described for macrophages.

recirculating water located in a room with laminar, high efficiency
particulate-filtered air. The animals received autoclaved food, water,
and bedding. Mice were handled in accordance with approved
protocols through the Institutional Animal Care and Use Committee
at the University of Cincinnati School of Medicine.

Static growth experiments
Previous studies have demonstrated that mucoid strains of P.
aeruginosa are capable of spontaneously reverting to a nonmucoid
phenotype and acquiring flagellum based motility in a static
growth conditions [28]. In this study, overnight cultures of two
mucoid CF isolates of P. aeruginosa strains, CF51 and CF90, were
inoculated into 5 ml LB in 186150 mM culture tubes. These
cultures were incubated at 37uC vertically in test tube racks
without shaking for 72 hr, and then plated on regular LB agar.
Individual nonmucoid colonies were replicated on swimming
motility agar plates (LB solidified with 0.3% agar) to confirm
reversion to motility phenotype.

Comparative screening of the P. aeruginosa STM
library in SP-A+/+ and SP-A2/2 mice
The P. aeruginosa PA01 STM library and screening methods were
previously described [19]. Briefly, SP-A+/+ and SP-A2/2mice
were anaesthetized using isofluorane and inoculated intranasally
with 16107 cells of individual STM pools of 72 mutants in 50 ml of
phosphate buffered saline buffer. After 16 hr of in vivo selection,
lungs were removed from sacrificed mice, homogenized, and
plated on LB agar. At least 10,000 bacterial colonies were
harvested for multiplex PCR as described previously [17,19].
Twenty sets of 72 mutants (total 1440) had been screened at the
time of this writing. An additional 240 mutants previously shown
to be attenuated in a chronic model of rat lung infection were also
screened [19]. The mutants that were differentially cleared by SPA during the in vivo passaging were subsequently retested by single
PCR of bacterial cells recovered from three separate mice as
previously described [17].

Flagellum-dependent swimming motility
Flagellum-dependent swimming motility was measured in fresh
swimming motility agar plates with or without antibiotics. Plates
were inoculated with 5 ml of an overnight culture of each strain of
same cell density (as determined by spectrophotometer) and then
incubated at 30uC for 24–48 hr. Motility was quantitatively
assessed by examining the radius of opacity from the inoculation
point, indicating the extent of bacterial swimming, compared to
that of the wild-type PA01.

Competitive and single infection assays in vivo
For competition assays, mice were inoculated intranasally with
16107 bacterial cells comprised of a 1:1 ratio of wild-type PA01 and
flgE. Lungs were harvested 16 hr after infection for bacterial load
determination. The competitive index (CI) is defined as the output
ratio of mutant to wild-type bacteria divided by the input ratio of
mutant to wild-type bacteria [21]. Thus, for a mutant strain that was
less competitive than the parental strain from which it was derived,
a CI value of ,1 would be achieved. Single infections with 16107
flgE cells were performed by the intranasal route in SP-A+/+ and SPA2/2 mice (group of five). Attenuation was defined as the log10
difference in CFU of flgE recovered from the lung tissues of SP-A+/+
and SP-A2/2 mice lung tissue 16 hr after inoculation.

P. aeruginosa membrane permeability assays
The effect of the SP-A or melittin on P. aeruginosa cell wall integrity
was assessed by determining permeability to a phosphatase substrate,
Enzyme-Labeled Fluorescence 97 (ELF-97, Molecular Probes) as
described [17]. SP-A (50 mg/ml) or melittin (5 mg/ml) was incubated
with 16108 logarithmic or stationary phase bacterial cells/ml in
100 ml of 5 mM Tris and 150 mM NaCl for 15 min at 37uC, and
100 mM ELF97 phosphatase substrate was added. Fluorescence was
measured at excitation and emission wavelengths of 355 and
535 nm, respectively, for a period of 120 min.

LIVE/DEAD bacterial staining
Alveolar macrophage and neutrophil phagocytosis
assays in vivo and in vitro

The viability of SP-A exposed bacteria was determined by LIVE/
DEAD baclightTM Bacterial Viability Kit (Molecular Probes, Cat.
No. L-7012). Briefly, stationary phase E. coli or P. aeruginosa
bacteria were washed three times with 5 mM Tris, 150 mM NaCl,
and adjusted to an OD600 of 1.0. A 100 ml aliquot of the cells was
added to culture tubes containing SP-A (100 mg/ml) in 100 ml of
5mM Tris, 150mM NaCl, or to buffer alone as control. The
mixtures were incubated at 37uC while shaking at 300 rpm for
1 hr, and stained according to the instructions provided by the
supplier. The viability of the cells was checked under a fluorescence
microscope. At least 1, 000 cells were counted.

For in vivo phagocytosis studies, 2.56108 GFP-expressing PA01 or
flgE bacteria were intranasally inoculated into SP-A+/+ and SPA2/2 mice. Two hours later, infected lungs were lavaged with
PBS to obtain alveolar macrophages. For in vitro studies, freshly
recovered mouse macrophages (,56105 cells from 3 uninfected
SPA2/2 mice) were adhered to chamber plastic culture slides,
coated with 5% poly-D-lysine in 200 ml RPMI (Dulbecco’s,
containing 2.5 mg/liter gentamycin and 0.1% BSA), for 2 hr at
37uC in 5% CO2 and used immediately. Live GFP-expressing
PA01 or flgE in RPMI were preincubated with or without 25 mg/
ml human SP-A for 1 hr at 37uC with rotation. The media was
removed from each well, replaced with 250 ml of opsonized PA01
or flgE, and incubated for 1 hr at 37uC in 5% CO2 at a ratio of
100 bacteria to 1 macrophage. Chamber slides were washed 3
times with PBS containing 1 mM CaCl2. Fluorescence from
extracellular bacteria was quenched with crystal violet (0.8 mg/
ml). Following two additional washes, cells were fixed with 1%
paraformaldehyde in PBS plus 1 mM CaCl2 for 10 min, and
stained with Evans blue for 2 min. The percentage of macrophages with engulfed bacteria was quantified by phase contrast
fluorescence microscopy. At least 200 macrophages were counted.
Human neutrophils were purified and cultured as previously
PLoS ONE | www.plosone.org

LPS purification and western blot analysis
P. aeruginosa PA01 and flgE cells were grown to late logarithmic or
stationary phase in LB at 37uC and concentrated to A560 1.5 in
PBS, and verified to contain the same viable cell counts (data not
shown). The resultant cell pellet from 500 ml of sample was
resuspended in 100 ml of PBS and incubated with or without
100 mg/ml of SP-A at 37uC for 30 min. An equal volume of
26sample buffer (6% SDS; 6% 2-mercaptoethanol; 10 mM
dithiothreitol; 46% glycerol; 60 mM Tris, pH 8.0; 0.1% bromophenol blue) was added. The samples were boiled for 10 min and
protein was digested by the addition of proteinase K to a final
concentration of 50 mg/ml at 37uC overnight. The samples were
9
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boiled again for 10 min and cooled down to room temperature. A
second volume of proteinase K, equal to the first, was added and
incubated at 55uC for 3 h. Gross LPS profiles were determined by
silver stain after SDS-PAGE electrophoresis.
Western blot analyses were performed as described [54]. Briefly,
LPS samples (15 ml) were resolved by SDS-PAGE and electroblotted to Immobilon P polyvinylidene difluoride membranes
(Millipore, Bedford, MA). The membranes were then incubated
for 60 min at room temperature in blocking solution (PBS
containing 3% bovine serum albumin), followed by a 4-hr
incubation with monoclonal antibodies against the inner core
(MAb 7–4) and B-band O-antigen (MAb MF15-4) (generously
provided by Dr. Joseph Lam, Guelph University), respectively.
The membranes were hybridized with horseradish peroxidaseconjugated goat anti-mouse IgG secondary antibody. The immune
complexes were visualized using the ECL Western Blotting
Detection System (Amershan Biosciences, Piscataway, New Jersey)
and Kodak BIOMAX (Kodak, Rochester, New York) X-ray films.

Statistical analyses
Statistical analysis was performed using the Student’s t-test and
one-way analyses of variance (ANOVA). A significant difference
was considered to be p,0.05.
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